Page last updated: 2024-09-03

4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide and Glial Cell Tumors

4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide has been researched along with Glial Cell Tumors in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu-Chen, LY; Traynor, JR; Wang, Q1

Other Studies

1 other study(ies) available for 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide and Glial Cell Tumors

ArticleYear
Differential modulation of mu- and delta-opioid receptor agonists by endogenous RGS4 protein in SH-SY5Y cells.
    The Journal of biological chemistry, 2009, Jul-03, Volume: 284, Issue:27

    Topics: Analgesics, Opioid; Animals; Benzamides; Cell Line, Tumor; Colforsin; Cyclic AMP; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Glioma; Glycosylation; Humans; Kidney; Mice; Mitogen-Activated Protein Kinases; Morphine; Neuroblastoma; Piperazines; Rats; Receptors, Opioid, delta; Receptors, Opioid, mu; Recombinant Fusion Proteins; RGS Proteins; RNA Interference; Signal Transduction; Transfection

2009